Lack of physical integrity of the upper gastrointestinal tract or malabsorption syndrome, or the inability to take oral medication
Subjects must have no barriers to taking oral medications, for example uncontrolled nausea, vomiting, diarrhea at baseline, lack of physical integrity of the upper gastrointestinal tract, or malabsorption syndrome
Lack of physical integrity of the upper gastrointestinal tract, malabsorption syndrome or inability to swallow
Patients unable to take oral drugs or with lack of physical integrity of the upper gastrointestinal tract or known malabsorption syndromes
Patients unable to take oral drugs or with lack of physical integrity of the upper gastrointestinal tract or known malabsorption syndromes
Lack of physical integrity of the upper gastrointestinal tract, malabsorption syndrome, or inability to swallow pills.
Malabsorption syndrome or poor upper gastrointestinal integrity
Gastrointestinal tract disease or defect with associated malabsorption syndrome
Active gastrointestinal tract disease with malabsorption syndrome
Lack of physical integrity of the upper gastrointestinal tract or malabsorption syndrome
Lack of physical integrity of the upper gastrointestinal tract or malabsorption syndrome
Lack of physical integrity of the upper gastrointestinal tract or malabsorption syndrome
Lack of physical integrity of the upper gastrointestinal tract or malabsorption syndrome (such as jejunostomy probe and gastric or jejunostomy tubes) which may impair the ability to administer or absorb capecitabine
Patients unable to take oral drugs (e.g. lack of physical integrity of the upper gastrointestinal [GI] tract or known malabsorption syndromes)
Patients unable to take oral drugs or with lack of physical integrity of the upper gastrointestinal tract or known malabsorption syndromes
